July 2012

GVK Biosciences (www.gvkbio.com) is leading Informatics Services provider with wide range of Products and Services across the R&D value chain. Considered a market leader in the development of MANUALLY curated databases, GVK BIOs databases on SAR, PK/Tox and other areas are widely used in the industry and their utility have been well documented in the scientific literature. For more information please log into www.gvkbio.com

About Authors:
Sriharsha Vardhan
SRM College of Pharmacy,
Chennai, Tamil Nadu
sriharshavardhan.51@gmail.com

ABSTRACT
The present study is formulating Rabeprazole modified release beads (Immediate and Time, Pulsatile Release) and to target the release of the drug in intestine and to avoid stability related problems. Preparation of immediate release (IR) Rabeprazole beads has done by drug layering process and barrier coated beads by providing an enteric coating membrane on IR beads. Timed release beads has done by providing a Film coating for IR and lag time coating for TPR (Timed, Pulsatile Release)  on enteric coated beads. Encapsulation Process and evaluation of enteric coated IR and TPR beads has done by physical evaluation and chemical evaluation. Stability studies have done for best quality Rabeprazole IR and TPR enteric coated beads formulations. Based on the results Formulation 3 and Formulation 9 were selected as the best formulation developed for Rabeprazole Dual Drug Release Capsules.

RASA Life Science Informatics, a Bio-Chemoinformatics company based in Pune, provides unmatchable training facilities to students and professionals in Life Science Informatics. We are now launching a 100% Job oriented Training program, Academic & Industrial Projects to enable anyone and everyone to get trained and get placed.

Post: Business Development Executive

BRAWN, with its inception barely 21 years back(1988) has today evolved into a fully integrated, healthcare group, marking its presence in India and dotting various major markets across the globe. With its claim of quality and certified with ISO 9001:2000, 13485, WHO : cGMP, BRAWN is proud to possess product registration with major health and govt. institutions throughout India and in many other countries worldwide.

Processing over 10 million tests a year, catering to more than 10,000 Laboratories, Hospitals, Nursing homes and 20,000 Consultants; and with 29 years of experience delivering accurate reports, Metropolis has also earned the reputation of being Indias only multinational chain of diagnostic centers with presence in the UAE, Sri Lanka, Mauritius, Bangladesh, Nepal and South Africa.

About Authors:
Pritesh R. Patel^*, Priyank Patel, Jagath Pillai, Nilesh Darji, Bhagirath Patel
Department of Pharmaceutical Chemistry,
Sat Kaival College of Pharmacy, Sarsa,
Ta & Dist: Anand (Gujarat), India-388365
*prit.pharma@gmail.com

ABSTRACT
As part of ongoing studies in developing new antimicrobials, a novel series of 4-acetamido-N-(substituted 1, 3-benzothiazol-2-yl) benzenesulphonamide and N-(substituted 1, 3-benzothiazol-2-yl)-4-(substituted aryl diazenyl) benzenesulphonamide were synthesized in order to determine their antibacterial and antifungal activity. The synthesized compounds were tested in vitro against two Gram-positive bacteria like Staphylococcus aureus, Bacillus subtilis; two Gram-negative bacteria like Escherichia coli, Pseudomonas aeruginosaand one fungal strain Candida albicans in comparison with standard drugs. Microbiological results showed that the synthesized compounds possessed a broad spectrum of antibacterial and antifungal activity against the tested microorganisms. The compounds with a 6-chloro (SK5b), 7-chloro-6-fluoro(SK5d) and 6-nitro (SK5e) on 2-amino benzothiazole ring possessing azo linkage showed better antimicrobial activity; almost similar or less to that of standard drugs thus they could be promising candidates for novel drugs. The novel heterocyclic derivatives were characterized by Physical characterization (Melting point, TLC) and different Spectroscopy techniques (IR, ¹H NMR and Mass spectroscopy).

Atul Ltd is a member of Lalbhai Group, one of the oldest business houses of India, with interests mainly in textiles and chemicals. The Group is strongly committed to serve the society in the fields of education, health as well as culture.

Pegasus Farmaco India Pvt Ltd is a quality driven pharmaceutical manufacturing and marketing company with an over a period of 16 years. Pegasus Farmaco has two state of the art manufacturing units for manufacturing quality formulations in Tablets, Capsules, Ointments forms. Apart from its ethical marketing of its own brands with an established marketing and distribution setup, the company has also rich experience in offering Contract manufacturing Services.